Pharmacogenomics of Human Drug Transporters: Clinical Impacts
Sets the foundation for safer, more effective drug therapies With this book as their guide, readers will discover how to apply our current understanding of the pharmacogenomics of drug transporters to advance their own drug discovery and development efforts. In particular, the book explains how new...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Somerset
John Wiley & Sons, Incorporated
2013
|
| Ausgabe: | 1st ed |
| Schlagworte: | |
| Zusammenfassung: | Sets the foundation for safer, more effective drug therapies With this book as their guide, readers will discover how to apply our current understanding of the pharmacogenomics of drug transporters to advance their own drug discovery and development efforts. In particular, the book explains how new findings in the field now enable researchers to more accurately predict drug interactions and adverse drug reactions. Moreover, it sets the foundation for the development of drug therapies that are tailored to an individual patient's genetics. Pharmacogenomics of Human Drug Transporters serves as a comprehensive guide to how transporters regulate the absorption, distribution, and elimination of drugs in the body as well as how an individual's genome affects those processes. The book's eighteen chapters have been authored by a team of leading pioneers in the field. Based on their own laboratory and clinical experience as well as a thorough review of the literature, these authors explore all facets of drug transporter pharmacogenomics, including: Individual drug transporters and transporter families and their clinical significance Principles of altered drug transport in drug-drug interactions, pharmacotherapy, and personalized medicine Emerging new technologies for rapid detection of genetic polymorphisms Clinical aspects of genetic polymorphisms in major drug transporter genes Future research directions of drug transporter pharmacogenomics and the prospect of individualized medicine Pharmacogenomics of Human Drug Transporters opens the door to new drug discovery and development breakthroughs leading to safer and more effective customized drug therapies.The book is recommended for pharmaceutical scientists, biochemists, pharmacologists, clinicians, and genetics and genomics researchers |
| Beschreibung: | Description based on publisher supplied metadata and other sources |
| Beschreibung: | 1 online resource (466 pages) |
| ISBN: | 9781118353257 9780470927946 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044050125 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 170217s2013 |||| o||u| ||||||eng d | ||
| 020 | |a 9781118353257 |9 978-1-118-35325-7 | ||
| 020 | |a 9780470927946 |c Print |9 978-0-470-92794-6 | ||
| 035 | |a (ZDB-30-PAD)EBC1154340 | ||
| 035 | |a (ZDB-89-EBL)EBL1154340 | ||
| 035 | |a (ZDB-38-EBR)ebr10674852 | ||
| 035 | |a (OCoLC)831117883 | ||
| 035 | |a (DE-599)BVBBV044050125 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 615.7 | |
| 100 | 1 | |a Ishikawa, Toshihisa |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Pharmacogenomics of Human Drug Transporters |b Clinical Impacts |
| 250 | |a 1st ed | ||
| 264 | 1 | |a Somerset |b John Wiley & Sons, Incorporated |c 2013 | |
| 264 | 4 | |c © 2013 | |
| 300 | |a 1 online resource (466 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Description based on publisher supplied metadata and other sources | ||
| 520 | |a Sets the foundation for safer, more effective drug therapies With this book as their guide, readers will discover how to apply our current understanding of the pharmacogenomics of drug transporters to advance their own drug discovery and development efforts. In particular, the book explains how new findings in the field now enable researchers to more accurately predict drug interactions and adverse drug reactions. Moreover, it sets the foundation for the development of drug therapies that are tailored to an individual patient's genetics. Pharmacogenomics of Human Drug Transporters serves as a comprehensive guide to how transporters regulate the absorption, distribution, and elimination of drugs in the body as well as how an individual's genome affects those processes. The book's eighteen chapters have been authored by a team of leading pioneers in the field. Based on their own laboratory and clinical experience as well as a thorough review of the literature, these authors explore all facets of drug transporter pharmacogenomics, including: Individual drug transporters and transporter families and their clinical significance Principles of altered drug transport in drug-drug interactions, pharmacotherapy, and personalized medicine Emerging new technologies for rapid detection of genetic polymorphisms Clinical aspects of genetic polymorphisms in major drug transporter genes Future research directions of drug transporter pharmacogenomics and the prospect of individualized medicine Pharmacogenomics of Human Drug Transporters opens the door to new drug discovery and development breakthroughs leading to safer and more effective customized drug therapies.The book is recommended for pharmaceutical scientists, biochemists, pharmacologists, clinicians, and genetics and genomics researchers | ||
| 650 | 4 | |a Drug carriers (Pharmacy) | |
| 650 | 4 | |a Genomics | |
| 650 | 4 | |a Pharmacogenomics | |
| 650 | 0 | 7 | |a Carrier-Proteine |0 (DE-588)4213127-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakogenetik |0 (DE-588)4271255-5 |2 gnd |9 rswk-swf |
| 655 | 7 | |8 1\p |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Pharmakogenetik |0 (DE-588)4271255-5 |D s |
| 689 | 0 | 1 | |a Carrier-Proteine |0 (DE-588)4213127-3 |D s |
| 689 | 0 | |8 2\p |5 DE-604 | |
| 700 | 1 | |a Kim, Richard B. |e Sonstige |4 oth | |
| 700 | 1 | |a König, Jörg |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |a Ishikawa, Toshihisa |t Pharmacogenomics of Human Drug Transporters : Clinical Impacts |
| 912 | |a ZDB-30-PAD |a ZDB-38-ESG | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029456970 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804177067267325952 |
|---|---|
| any_adam_object | |
| author | Ishikawa, Toshihisa |
| author_facet | Ishikawa, Toshihisa |
| author_role | aut |
| author_sort | Ishikawa, Toshihisa |
| author_variant | t i ti |
| building | Verbundindex |
| bvnumber | BV044050125 |
| collection | ZDB-30-PAD ZDB-38-ESG |
| ctrlnum | (ZDB-30-PAD)EBC1154340 (ZDB-89-EBL)EBL1154340 (ZDB-38-EBR)ebr10674852 (OCoLC)831117883 (DE-599)BVBBV044050125 |
| dewey-full | 615.7 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.7 |
| dewey-search | 615.7 |
| dewey-sort | 3615.7 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | 1st ed |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03767nmm a2200529zc 4500</leader><controlfield tag="001">BV044050125</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170217s2013 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781118353257</subfield><subfield code="9">978-1-118-35325-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780470927946</subfield><subfield code="c">Print</subfield><subfield code="9">978-0-470-92794-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PAD)EBC1154340</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL1154340</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-38-EBR)ebr10674852</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)831117883</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044050125</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.7</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ishikawa, Toshihisa</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmacogenomics of Human Drug Transporters</subfield><subfield code="b">Clinical Impacts</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Somerset</subfield><subfield code="b">John Wiley & Sons, Incorporated</subfield><subfield code="c">2013</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (466 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Sets the foundation for safer, more effective drug therapies With this book as their guide, readers will discover how to apply our current understanding of the pharmacogenomics of drug transporters to advance their own drug discovery and development efforts. In particular, the book explains how new findings in the field now enable researchers to more accurately predict drug interactions and adverse drug reactions. Moreover, it sets the foundation for the development of drug therapies that are tailored to an individual patient's genetics. Pharmacogenomics of Human Drug Transporters serves as a comprehensive guide to how transporters regulate the absorption, distribution, and elimination of drugs in the body as well as how an individual's genome affects those processes. The book's eighteen chapters have been authored by a team of leading pioneers in the field. Based on their own laboratory and clinical experience as well as a thorough review of the literature, these authors explore all facets of drug transporter pharmacogenomics, including: Individual drug transporters and transporter families and their clinical significance Principles of altered drug transport in drug-drug interactions, pharmacotherapy, and personalized medicine Emerging new technologies for rapid detection of genetic polymorphisms Clinical aspects of genetic polymorphisms in major drug transporter genes Future research directions of drug transporter pharmacogenomics and the prospect of individualized medicine Pharmacogenomics of Human Drug Transporters opens the door to new drug discovery and development breakthroughs leading to safer and more effective customized drug therapies.The book is recommended for pharmaceutical scientists, biochemists, pharmacologists, clinicians, and genetics and genomics researchers</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug carriers (Pharmacy)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genomics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacogenomics</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Carrier-Proteine</subfield><subfield code="0">(DE-588)4213127-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakogenetik</subfield><subfield code="0">(DE-588)4271255-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmakogenetik</subfield><subfield code="0">(DE-588)4271255-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Carrier-Proteine</subfield><subfield code="0">(DE-588)4213127-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kim, Richard B.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">König, Jörg</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="a">Ishikawa, Toshihisa</subfield><subfield code="t">Pharmacogenomics of Human Drug Transporters : Clinical Impacts</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PAD</subfield><subfield code="a">ZDB-38-ESG</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029456970</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV044050125 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:42:11Z |
| institution | BVB |
| isbn | 9781118353257 9780470927946 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029456970 |
| oclc_num | 831117883 |
| open_access_boolean | |
| physical | 1 online resource (466 pages) |
| psigel | ZDB-30-PAD ZDB-38-ESG |
| publishDate | 2013 |
| publishDateSearch | 2013 |
| publishDateSort | 2013 |
| publisher | John Wiley & Sons, Incorporated |
| record_format | marc |
| spelling | Ishikawa, Toshihisa Verfasser aut Pharmacogenomics of Human Drug Transporters Clinical Impacts 1st ed Somerset John Wiley & Sons, Incorporated 2013 © 2013 1 online resource (466 pages) txt rdacontent c rdamedia cr rdacarrier Description based on publisher supplied metadata and other sources Sets the foundation for safer, more effective drug therapies With this book as their guide, readers will discover how to apply our current understanding of the pharmacogenomics of drug transporters to advance their own drug discovery and development efforts. In particular, the book explains how new findings in the field now enable researchers to more accurately predict drug interactions and adverse drug reactions. Moreover, it sets the foundation for the development of drug therapies that are tailored to an individual patient's genetics. Pharmacogenomics of Human Drug Transporters serves as a comprehensive guide to how transporters regulate the absorption, distribution, and elimination of drugs in the body as well as how an individual's genome affects those processes. The book's eighteen chapters have been authored by a team of leading pioneers in the field. Based on their own laboratory and clinical experience as well as a thorough review of the literature, these authors explore all facets of drug transporter pharmacogenomics, including: Individual drug transporters and transporter families and their clinical significance Principles of altered drug transport in drug-drug interactions, pharmacotherapy, and personalized medicine Emerging new technologies for rapid detection of genetic polymorphisms Clinical aspects of genetic polymorphisms in major drug transporter genes Future research directions of drug transporter pharmacogenomics and the prospect of individualized medicine Pharmacogenomics of Human Drug Transporters opens the door to new drug discovery and development breakthroughs leading to safer and more effective customized drug therapies.The book is recommended for pharmaceutical scientists, biochemists, pharmacologists, clinicians, and genetics and genomics researchers Drug carriers (Pharmacy) Genomics Pharmacogenomics Carrier-Proteine (DE-588)4213127-3 gnd rswk-swf Pharmakogenetik (DE-588)4271255-5 gnd rswk-swf 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content Pharmakogenetik (DE-588)4271255-5 s Carrier-Proteine (DE-588)4213127-3 s 2\p DE-604 Kim, Richard B. Sonstige oth König, Jörg Sonstige oth Erscheint auch als Druck-Ausgabe Ishikawa, Toshihisa Pharmacogenomics of Human Drug Transporters : Clinical Impacts 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Ishikawa, Toshihisa Pharmacogenomics of Human Drug Transporters Clinical Impacts Drug carriers (Pharmacy) Genomics Pharmacogenomics Carrier-Proteine (DE-588)4213127-3 gnd Pharmakogenetik (DE-588)4271255-5 gnd |
| subject_GND | (DE-588)4213127-3 (DE-588)4271255-5 (DE-588)4143413-4 |
| title | Pharmacogenomics of Human Drug Transporters Clinical Impacts |
| title_auth | Pharmacogenomics of Human Drug Transporters Clinical Impacts |
| title_exact_search | Pharmacogenomics of Human Drug Transporters Clinical Impacts |
| title_full | Pharmacogenomics of Human Drug Transporters Clinical Impacts |
| title_fullStr | Pharmacogenomics of Human Drug Transporters Clinical Impacts |
| title_full_unstemmed | Pharmacogenomics of Human Drug Transporters Clinical Impacts |
| title_short | Pharmacogenomics of Human Drug Transporters |
| title_sort | pharmacogenomics of human drug transporters clinical impacts |
| title_sub | Clinical Impacts |
| topic | Drug carriers (Pharmacy) Genomics Pharmacogenomics Carrier-Proteine (DE-588)4213127-3 gnd Pharmakogenetik (DE-588)4271255-5 gnd |
| topic_facet | Drug carriers (Pharmacy) Genomics Pharmacogenomics Carrier-Proteine Pharmakogenetik Aufsatzsammlung |
| work_keys_str_mv | AT ishikawatoshihisa pharmacogenomicsofhumandrugtransportersclinicalimpacts AT kimrichardb pharmacogenomicsofhumandrugtransportersclinicalimpacts AT kanigjarg pharmacogenomicsofhumandrugtransportersclinicalimpacts |